MSTARS has a dual research focus aiming for the advancement of mass spectrometry based technologies to implement these in clinical routines and for a better understanding of therapy resistances to support therapy recommendations. To achieve these goals experts in MS based proteomics, metabolomics, and imaging technologies teamed up with bioinformaticians and clinicians.